Výsledky vyhledávání

Akademický článek

Oral History and Public Memories edited by Paula Hamilton and Linda Shopes

Autor: Jay Price

Publikováno v: Public History Review, Vol 16 (2009)

Externí odkaz: https://doaj.org/article/d89dacac48ad4e8fb164310b6bee383a

Akademický článek

SPAR – a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial

Autor: Michael B. Jameson, Kirsten Gormly, David Espinoza, Wendy Hague, Gholamreza Asghari, Grahame Mark Jeffery, Timothy Jay Price, Christos Stelios Karapetis, Michael Arendse, James Armstrong, John Childs, Frank A. Frizelle, Sam Ngan, Andrew Stevenson, Martinus Oostendorp, Stephen P. Ackland

Publikováno v: BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)

Abstract Background Retrospective studies show improved outcomes in colorectal cancer patients if taking statins, including overall survival, pathological response of rectal cancer to preoperative chemoradiotherapy (pCRT), and reduced acute and late

Externí odkaz: https://doaj.org/article/631cd481e261422aa5a9a4ae454d866e

Zobrazit plný text záznamu

Plný text ve formátu HTML

Phase I Trial of nab-Paclitaxel Administered Concurrently With Radiotherapy in Patients With Locally Advanced Inoperable Pancreatic Adenocarcinoma

Autor: Amitesh Chandra Roy, M. Nazim Abbas, Timothy Jay Price, Nimit Singhal, Sina Vatandoust, John Leung, Ganessan Kichenadasse, Bogda Koczwara, Shawgi Sukumaran, Rajiv Kumar, Richard Woodman, Alex Scott-Hoy, Christos Stelios Karapetis

Publikováno v: Pancreas. 51:490-495

Nab-paclitaxel has radiosensitizing antitumor efficacy in pancreatic cancer. We aimed to establish maximum tolerated dose (MTD) of nab-paclitaxel with radiotherapy in unresectable locally advanced pancreatic cancer.In a phase I dose escalation trial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c695571645ebaaaa0dfc16ea1e7c7843
https://doi.org/10.1097/mpa.0000000000002065

Zobrazit plný text záznamu

nextHERIZON: A phase 2 study of HER-Vaxx, a HER2-targeting peptide vaccine, in combination with chemotherapy or pembrolizumab in patients with HER2 metastatic or advanced gastric/gastroesophageal adenocarcinoma that progressed on or after trastuzumab treatment

Autor: Timothy Jay Price, Leslie Mi Ok Chong, Nicholas Ede, Bonnie Nixon, Nimali Withana, Sharon Yavrom, Giovanni Selvaggi, Anthony J. Good

Publikováno v: Journal of Clinical Oncology. 41:TPS481-TPS481

TPS481 Background: HER-Vaxx is a B-cell peptide vaccine composed of a fusion of 3 epitopes from the extracellular domain of HER2/neu conjugated to CRM197 with the adjuvant Montanide. Results from a phase 1b study revealed that active immunization wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1cbd4557948c8b7fb6a4934c2ed9409c
https://doi.org/10.1200/jco.2023.41.4_suppl.tps481

Zobrazit plný text záznamu

Prognostic Differences of RAS Mutations: Results from the South Australian Metastatic Colorectal Registry

Autor: Anas, Alawawdeh, Cynthia, Piantadosi, Amanda Rose, Townsend, Christos Stelios, Karapetis, Rob, Padbury, Amitesh Chandra, Roy, James, Moore, Guy, Maddern, David, Roder, Annabelle, Smith, Timothy Jay, Price

Publikováno v: Targeted oncology. 17(1)

Effective targeting of RAS mutations has proven elusive until recently. Novel agents directly targeting KRAS G12C have shown promise in early-phase clinical trials that included patients with metastatic colorectal cancer. Prior reports have suggested

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::283e640aacb3567cf8c37391ef988e96
https://pubmed.ncbi.nlm.nih.gov/34822070

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání